What is Start?
Start LLC operates as a specialized powerhouse in the medical product development ecosystem, offering a comprehensive suite of services that spans from initial strategy and industrial design to complex engineering and rapid prototyping. With a legacy exceeding three decades, the firm has established itself as a critical partner for healthcare entities seeking to bring sophisticated medical, surgical, home health, and rehabilitation devices to market.
The company's technical prowess is evidenced by its successful track record, including the development of the CardioFocus Heartlight Console and the Stretta 3 GERD Treatment Device. By integrating deep clinical insights with advanced manufacturing capabilities, Start LLC ensures that its clients achieve commercial viability and regulatory success. Their business model is built upon a foundation of technical excellence, allowing them to navigate the stringent requirements of the medical device industry while maintaining a focus on patient-centric innovation.
How much funding has Start raised?
Start has raised a total of $109K across 1 funding round:
Debt
$109K
Debt (2021): $109K with participation from PPP
Key Investors in Start
PPP
Public-Private Partnership
What's next for Start?
With the successful closure of this late-stage funding, Start LLC is poised to deepen its market penetration and refine its service offerings. The strategic deployment of these funds will likely focus on optimizing the commercialization pipeline for next-generation surgical tools and expanding the firm's capacity for high-fidelity prototyping. As the healthcare sector continues to prioritize minimally invasive and home-based care solutions, Start LLC is strategically aligned to capitalize on these emerging trends.
Looking ahead, the company is expected to leverage its extensive patent library to forge new partnerships and potentially explore inorganic growth opportunities. By maintaining its commitment to engineering excellence and strategic planning, Start LLC remains a pivotal player in the evolution of medical technology, ensuring that its clients remain at the forefront of clinical innovation and market competitiveness.